Trauma Activation Criteria
Trauma Activation Criteria Refinement
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Crystee Cooper, DHEd
- Phone Number: 214-947-1280
- Email: ClinicalResearch@mhd.com
Study Contact Backup
- Name: Kavya Mankulangara
- Phone Number: 214-947-4604
- Email: ClinicalResearch@mhd.com
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75203
- Recruiting
- Methodist Dallas Medical Center- Clinical Research Institute
-
Contact:
- Kavya Mankulangara
- Phone Number: 214-947-4604
- Email: ClinicalResearch@mhd.com
-
Contact:
- Colette Ngo Ndjom
- Phone Number: 214-947-1289
- Email: ClinicalResearch@mhd.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
Patient is included in the Methodist Dallas Medical Center trauma registry. Trauma patients who recieved care at Methodist Dallas Medical Center between November 24, 2023 and November 25, 2025.
Exclusion Criteria:
Patient does not meet registry inclusion criteria.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Methodist Dallas Medical Center trauma registry
Trauma patients who recieved care at Methodist Dallas Medical Center between November 24, 2023 and November 25, 2025.
|
To quantify the over- and under-triage rates as relative to trauma activation criteria reform.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Determine the over/under-triage rates
Time Frame: 2 year
|
The project will be evaluated by comparing the over- and under-triage rates of the historical criteria and the reformed criteria.
As the criteria reform was live November 25, 2024, pre-implementation will be defined as November 24, 2023 - November 24, 2024 and post-implementation will be defined as November 25, 2024 - November 25, 2025.
|
2 year
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Jennifer Burris, MD, Methodist Health System
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 047.TRA.2024.D
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.